CARE
Overvalued by 11.8% based on the discounted cash flow analysis.
Market cap | $403.89 Million |
---|---|
Enterprise Value | $314.89 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.06 |
Beta | 0.76 |
Outstanding Shares | 22,874,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 14.42 |
---|---|
PEG | 26.67 |
Price to Sales | 1.93 |
Price to Book Ratio | 1.02 |
Enterprise Value to Revenue | 1.44 |
Enterprise Value to EBIT | 19.29 |
Enterprise Value to Net Income | 11 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data